Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). [Phase 2]

View source ↗

Summary

Phase 2 study evaluating an IL4Rα monoclonal antibody for seasonal allergic rhinitis; the trial is currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• IL4Rα monoclonal antibody (IL4Rα monoclonal antibody)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Allergic Rhinitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING